Furniture Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Furniture Press Releases.

Press releases published on June 4, 2026

Jun. 4, 2026

Option Care Health Appoints Robert Okunski as Vice President, Investor Relations

Indeterminate GlobeNewswire

Jun. 4, 2026

Plug to Webcast Annual Shareholder Meeting on June 11, 2026

Indeterminate GlobeNewswire

Jun. 4, 2026

Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting

Indeterminate GlobeNewswire

Jun. 4, 2026

B2U and Waymo Launch Landmark Partnership to Give Autonomous Fleet Batteries a Second Life

Indeterminate GlobeNewswire

Jun. 4, 2026

U.S. Energy Corp. Announces Corporate Rebrand to Big Sky Industrial Inc.

Indeterminate GlobeNewswire

Jun. 4, 2026

AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society

Indeterminate GlobeNewswire

Jun. 4, 2026

PyroGenesis Announces Closing of $2 Million Private Placement

Indeterminate GlobeNewswire

Jun. 4, 2026

PyroGenèse annonce la clôture d’un placement privé de 2 millions de dollars

Indeterminate GlobeNewswire

Jun. 4, 2026

Electra Awards Structural, Mechanical & Piping Contract

Indeterminate GlobeNewswire

Jun. 4, 2026

Fractyl Health Reports Positive One-Year REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

Indeterminate GlobeNewswire

Jun. 4, 2026

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Jun. 4, 2026

Gogo secures $7.5 million NOAA contract, providing mission-critical communications services for ‘hurricane hunter’ aircraft

Indeterminate GlobeNewswire

Jun. 4, 2026

Attralus Therapeutic Zamubafusp Alfa (AT-02) Receives U.S. FDA Orphan Drug Designation for the Treatment of AL Amyloidosis

Indeterminate GlobeNewswire

Jun. 4, 2026

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026

Indeterminate GlobeNewswire

Jun. 4, 2026

Orion Reports FY 2026 Revenue of $86M and Adjusted EBITDA of $2.2M After Continued Growth in Q4; Reiterates FY 2027 Expectation of $95M-$97M in Revenue and Positive Adjusted EBITDA

Indeterminate GlobeNewswire

Jun. 4, 2026

BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value

Indeterminate GlobeNewswire

Jun. 4, 2026

Syndax Announces Private Placement of $250.0 Million of Convertible Senior Notes

Indeterminate GlobeNewswire

Jun. 4, 2026

Toronto’s Top 100 Restaurants to Dine for Under $100: Toronto Star Reveals New Curated List for Anyone Who Wants to Go Out

Indeterminate GlobeNewswire

Jun. 4, 2026

Breckenridge Distillery Introduces Breckenridge Rye Whiskey, A Bold New Expression from the World’s Highest Distillery

Indeterminate GlobeNewswire

Jun. 4, 2026

Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial

Indeterminate GlobeNewswire